US Compounding Inc. has recalled 1,534 syringes of Succinylcholine Chloride PF Injection (200 mg/10 mL). This prescription muscle relaxant is being recalled because the lot number and Beyond Use Date (BUD) were printed in the wrong position on the label, making them impossible to read. This defect prevents healthcare providers from verifying if the medication is expired or correctly identified in the event of a quality issue. Patients or facilities with these syringes should immediately contact their healthcare provider or pharmacist for guidance and to arrange for a refund of any unused product.
Illegible expiration dates and lot numbers on a critical medication can lead to the accidental use of expired drugs, which may have reduced potency or safety. This poses a risk to patients undergoing procedures where precise muscle relaxation is required.
Drug recall remedy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.